BMBF Förderschwerpunkt Klinische Studien – Systematische Reviews zur Borderline-Persönlichkeitsstörung
Laufzeit: 01.01.2006 - 31.12.2008
Laufzeit: 01.01.2006 - 31.12.2008
Borderline Personality Disorder is highly prevalent and characterized by emotional dysregulation, impulsivity, self-injurious behavior and suicidality. Although many RCTs have been published on the treatment of BPD, no consensus exists how to best manage patients with BPD. This proposal aims to perform systematic reviews (including metaanalyses where possible) on psychological and pharmacological treatments of BPD, to systematically assess patient-related or other factors contributing...Borderline Personality Disorder is highly prevalent and characterized by emotional dysregulation, impulsivity, self-injurious behavior and suicidality. Although many RCTs have been published on the treatment of BPD, no consensus exists how to best manage patients with BPD. This proposal aims to perform systematic reviews (including metaanalyses where possible) on psychological and pharmacological treatments of BPD, to systematically assess patient-related or other factors contributing significantly to treatment outcome, to produce and disseminate reports of these reviews and to formulate research recommendations for the design of controlled trials of sound methodological quality.» weiterlesen» einklappen